Kiniksa Pharmaceuticals International, plc Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2020-11-23: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2019-03-08; Total offering amount $8,799,667.
- 2019-07-11: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2019-03-08; Total offering amount $7,479,822.
- 2019-04-04: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2019-03-08; Total offering amount $5,949,876.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2020-11-23 D/A | Rule 506(b) | Equity | 2019-03-08 | $8,799,667 | $8,799,667 | $0 | 10 |
| 2019-07-11 D/A | Rule 506(b) | Equity | 2019-03-08 | $7,479,822 | $7,479,822 | $0 | 10 |
| 2019-04-04 | Rule 506(b) | Equity | 2019-03-08 | $5,949,876 | $5,949,876 | $0 | 10 |